Finance

Lists
Why is ATTO down 6.17%?
Dive Deeper
ATTO:NASDAQ
Attovia Therapeutics Inc
$16.42
-6.17%
(-1.08) 1D
$16.42
0.00% (0.00)
After hours
Closed: Oct 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATTO...
Open
$17.40
High
$17.54
Low
$16.33
Mkt. cap
749.59M
Avg. vol.
366.86K
Volume
10.00
52-wk high
$28.00
52-wk low
$16.15
EPS
-$1.64
No. of employees
44
Open
$17.40
High
$17.54
Low
$16.33
Mkt. cap
749.59M
Avg. vol.
366.86K
Volume
10.00
52-wk high
$28.00
52-wk low
$16.15
EPS
-$1.64
No. of employees
44
News stories
From web sources and news partners
About Attovia Therapeutics Inc
CEO-
Employees44
Founded2022
HeadquartersSan Carlos, California, United States
SectorBiotechnology
Websiteattovia.com
Analyst ratings
Based on 4 analysts giving stock ratings to ATTO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ATTO in the last 3 months.
Highest
Current $16.42
$45.00 (+174.06%)
Average
$39.75 (+142.08%)
Lowest
$30.00 (+82.70%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yigal Nochomovitz
Citi
Buy
Maintained
$30.00
+82.7%
09/03/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$45.00
+174.1%
09/05/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
$39.00
+137.5%
09/03/2026
Brian Abrahams
RBC Capital
Buy
Maintained
$45.00
+174.1%
09/02/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Mar 2026
Jun 2026
Revenue
-
-
-
450.00K
Cost of goods sold
11.70M
13.40M
16.51M
18.70M
Cost of revenue
11.70M
13.40M
16.51M
18.70M
Research and development expenses
154.00K
184.00K
239.00K
241.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.25M
3.03M
3.21M
3.31M
Operating expense
4.40M
3.22M
3.45M
3.55M
Total operating expenses
16.10M
16.62M
19.96M
22.25M
Operating income
-16.10M
-16.62M
-19.96M
-21.80M
Other non operating income
-173.00K
140.00K
-27.00K
-25.00K
EBT including unusual items
-15.15M
-14.44M
-18.66M
-20.69M
EBT excluding unusual items
-15.15M
-14.44M
-18.66M
-20.69M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15.15M
-14.44M
-18.66M
-20.69M
Net profit margin
-
-
-
-4,597.11%
Earnings per share
-
-
-
-4.88
Interest and investment income
1.13M
2.04M
1.33M
1.14M
Interest expense
-
-
-
-
Net interest expenses
1.13M
2.04M
1.33M
1.14M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.96M
-16.41M
-19.71M
-21.56M
Gain or loss from assets sale
6.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps